Across TCGA pan-cancer cohorts, C2orf78 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of C2orf78’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where C2orf78 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types C2orf78 is over-expressed in tumor.
KIRP, LUAD, and LUSC are the cancer types where C2orf78 tumor–normal differential expression is most reproducible.